As of Apr 25
| -0.0074 / -0.85%|
The 5 analysts offering 12-month price forecasts for Genocea Biosciences Inc have a median target of 3.00, with a high estimate of 5.00 and a low estimate of 2.00. The median estimate represents a +246.34% increase from the last price of 0.87.
The current consensus among 5 polled investment analysts is to Buy stock in Genocea Biosciences Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.